Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05320146 · ClinicalTrials.gov registry record
A Sub Study of the Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Patients With Presumed Nonalcoholic Steatohepatitis (NASH)
A clinical trial, sponsored by Corcept Therapeutics.
- Completed
- Registry status
- 22
- Enrollment target
NCT05320146 is a clinical trial that has completed, run by Corcept Therapeutics. The registered enrollment target is 22 participants.
The verdict
NCT05320146 has completed, sponsored by Corcept Therapeutics.
- COMPLETED
- Registry status
- 22 participants
- Enrollment target
Study Summary
This optional sub study is a part of the phase 1b, Open-Label Study is to assess the safety, efficacy of miricorilant in patients with presumed Nonalcoholic Steatohepatitis (NASH)
Interventions
- OTHER MRI-PDFF
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2022-03-04 |
| Est. Completion | 2023-07-18 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05320146
The ClinicalTrials.gov registry entry for NCT05320146 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Corcept Therapeutics, which has 54 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MRI-PDFF is the first listed.
NCT05320146 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05320146 about?
NCT05320146 is a clinical study titled "A Sub Study of the Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Patients With Presumed Nonalcoholic Steatohepatitis (NASH)". This optional sub study is a part of the phase 1b, Open-Label Study is to assess the safety, efficacy of miricorilant in patients with presumed Nonalcoholic Steatohepatitis (NASH)
What is the current status of trial NCT05320146?
This trial is currently completed. The enrollment target is 22 participants. The study started on 2022-03-04. Estimated completion is 2023-07-18.
What interventions are being tested in trial NCT05320146?
The interventions under investigation include: MRI-PDFF (OTHER).
Who is sponsoring clinical trial NCT05320146?
This trial is sponsored by Corcept Therapeutics, which has 54 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.